IPL 2021’s remainder to be held in UAE in September-October, says BCCI

The 2021 edition of the IPL was suspended with immediate effect on May 4 after players across multiple teams tested positive for COVID-19.

Moneycontrol News

May 29, 2021 / 14:00 IST

The Indian Premier League trophy (Image courtesy: Twitter/@IPL, BCCI)

The remainder of the 2021 Indian Premier League (IPL) season has been moved to the United Arab Emirates (UAE), the BCCI announced on May 29.

Considering the monsoon season in India, remaining matches of IPL 2021 will be played in the months of September and October this year, the Board of Control for Cricket in India (BCCI) said in a media statement.

The decision was taken at a special general meeting held virtually, where board members unanimously agreed to resume IPL, BCCI Secretary Jay Shah said in the statement.

The 2021 edition of the IPL was suspended with immediate effect on May 4 after players across multiple teams tested positive for COVID-19. At the time of suspension, the season was in its league stage which would have been followed by the Playoffs. The final was to be held on May 30.

The IPL Governing Council has not yet formally announced the exact dates and the new schedule. About 31 more matches are still left to be played.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show